PHARMOSA BIOPHARM INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 6875 for the last quarter is 40.90 M TWD, and it's 328.67% higher compared to the previous quarter. The net income of Q3 24 is -90.06 M TWD.